Results 91 to 100 of about 14,654 (172)

Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus. [PDF]

Commun Biol, 2021
Jansson D, Dieriks VB, Rustenhoven J, Smyth LCD, Scotter E, Aalderink M, Feng S, Johnson R, Schweder P, Mee E, Heppner P, Turner C, Curtis M, Faull R, Dragunow M.   +14 more
europepmc   +1 more source

Genomic basis of adaptation to cardiac glycosides in three insect orders. [PDF]

Front Genet
Zhu K, Zhu C, Zhen Y.
europepmc   +1 more source

Cardiac glycosides in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Wang D, Xu X, Lu J, Gao J, Li Y, Pan G, Peng W.   +6 more
europepmc   +1 more source

Repurposing of NKA inhibitors ('cardiac glycosides'): a critical analysis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Evans K, Seifert R.
europepmc   +1 more source

Deciphering Multitarget Mechanisms of Cardiac Glycosides in Acute Myeloid Leukemia Using a Network Pharmacology and Molecular Docking. [PDF]

Drug Des Devel Ther
Samart P, Poohadsuan J, Chanthateyanonth S, Issaragrisil S, Luanpitpong S.   +4 more
europepmc   +1 more source

Cardiac Glycosides: From Natural Defense Molecules to Emerging Therapeutic Agents. [PDF]

Biomolecules
Ponce A, Flores-Maldonado C, Contreras RG.   +2 more
europepmc   +1 more source

Inhibition of the Na⁺/K⁺-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation. [PDF]

J Biol Chem, 2022
Shandell MA, Capatina AL, Lawrence SM, Brackenbury WJ, Lagos D.   +4 more
europepmc   +1 more source

Rotation Conformational Effects of Selected Cytotoxic Cardiac Glycosides on Their Interactions with Na⁺/K⁺-ATPase. [PDF]

Molecules
Ren Y, Yang P, Gallucci JC, Wang C, Cheng X, Wu S, Kinghorn AD.   +6 more
europepmc   +1 more source

[Cardiac glycosides].

Acta poloniae pharmaceutica, 2003
T, KOPPANYI, J J, LEONARD
  +9 more sources

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment. [PDF]

Adv Sci (Weinh)
Ye ZH, Yu WB, Huang MY, Chen YY, Zhang LL, Leung CH, Zhang XL, Tang Z, Li T, Lu JJ.   +9 more
europepmc   +1 more source